ADSL and bacterial infectious disease: We examine: (i) if the presence of the gut microbiota affects gene expression of AMPs; (ii) whether there are corresponding shifts in peptide concentrations in the gut lumen and haemolymph; (iii) if member species of the gut microbiota are resistant to bee AMPs and (iv) if the gut microbiota is beneficial to host survival after wounding and bacterial infection.